Equecabtagene Autoleucel (Fucaso) was approved by China’s National Medical Products Administration (NMPA) on June 30, 2023, for treating adult patients with relapsed or refractory multiple myeloma ...

BUSHKILL, Pa. – A day after the Warren County Board of Commissioners reversed its decision to support a national park designation, the Delaware Water Gap Recreation Area announced Thursday that ...

Probationary employees across the FDA received notices Saturday evening that their jobs were being eliminated, according to three FDA staffers who spoke to The Associated Press on condition of ...

Although Katie said she had not put the guidance from the FDA, the European Medicines Agency (EMA) and China’s National Medical Products Administration (NMPA) side by side, she did believe that the ...